(Q52033532)

English

A phase II study in patients with Alzheimer's disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exelon).

scientific article published in July 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10362894

A phase II study in patients with Alzheimer's disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exelon). (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10362894

0 references

Alzheimer's disease

1 reference

based on heuristic

inferred from title

author name string

F Forette

1

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10362894

R Anand

2

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10362894

G Gharabawi

3

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10362894

publication date

1 July 1999

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10362894

European Journal of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10362894

6

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10362894

4

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10362894

423-429

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10362894

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1999.640423.X

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1999.640423.X

21 January 2018

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1999.640423.X

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1999.640423.X

21 January 2018

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1999.640423.X

21 January 2018

A new rating scale for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1999.640423.X

21 January 2018

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1999.640423.X

21 January 2018

Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1999.640423.X

21 January 2018

Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1999.640423.X

21 January 2018

Identifiers

10.1046/J.1468-1331.1999.640423.X

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10362894

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10362894

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52033532&oldid=1503569713"